Yu Z - Search Results

1

Serum ribonucleotide reductase M2 is a potential biomarker for diagnosing and monitoring liver fibrosis in chronic hepatitis B patients.

Zhan Y, Tao Q, Lang Z, Lin L, Li X, Yu S, Yu Z, Zhou G, Wu K, Zhou Z, Yu Z, Zheng J. Zhan Y, et al. Among authors: yu s, yu z. J Med Virol. 2023 Oct;95(10):e29157. doi: 10.1002/jmv.29157. J Med Virol. 2023. PMID: 37814947

2

Signature Construction and Molecular Subtype Identification Based on Pyroptosis-Related Genes for Better Prediction of Prognosis in Hepatocellular Carcinoma.

Chen J, Tao Q, Lang Z, Gao Y, Jin Y, Li X, Wang Y, Zhang Y, Yu S, Lv B, Yu Z, Lin C. Chen J, et al. Among authors: yu s, yu z. Oxid Med Cell Longev. 2022 Jan 11;2022:4494713. doi: 10.1155/2022/4494713. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35069975 Free PMC article.

3

Chen B, Yang Z, Lang Z, Tao Q, Zhang R, Zhan Y, Xu X, Zhu K, Zheng J, Yu Z, Yu S. Chen B, et al. Among authors: yu s, yu z. BMC Cancer. 2022 Aug 9;22(1):867. doi: 10.1186/s12885-022-09925-2. BMC Cancer. 2022. PMID: 35941582 Free PMC article.

4

Construction of a novel exosomes-related gene signature in hepatocellular carcinoma.

Tao Q, Zhu K, Zhan Y, Zhang R, Lang Z, Yu Z, Wang M. Tao Q, et al. Among authors: yu z. Front Cell Dev Biol. 2022 Aug 29;10:997734. doi: 10.3389/fcell.2022.997734. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36105354 Free PMC article.

5

Machine learning identifies exosome features related to hepatocellular carcinoma.

Zhu K, Tao Q, Yan J, Lang Z, Li X, Li Y, Fan C, Yu Z. Zhu K, et al. Among authors: yu z. Front Cell Dev Biol. 2022 Sep 19;10:1020415. doi: 10.3389/fcell.2022.1020415. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36200042 Free PMC article.

6

A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma.

Yang Z, Li X, Pan C, Li Y, Lin L, Jin Y, Zheng J, Yu Z. Yang Z, et al. Among authors: yu z. BMC Cancer. 2022 Dec 22;22(1):1344. doi: 10.1186/s12885-022-10463-0. BMC Cancer. 2022. PMID: 36550445 Free PMC article.

7

Machine learning integrations develop an antigen-presenting-cells and T-Cells-Infiltration derived LncRNA signature for improving clinical outcomes in hepatocellular carcinoma.

Wang X, Chen J, Lin L, Li Y, Tao Q, Lang Z, Zheng J, Yu Z. Wang X, et al. Among authors: yu z. BMC Cancer. 2023 Mar 28;23(1):284. doi: 10.1186/s12885-023-10766-w. BMC Cancer. 2023. PMID: 36978017 Free PMC article.

8

Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells.

Lang Z, Li Y, Lin L, Li X, Tao Q, Hu Y, Bao M, Zheng L, Yu Z, Zheng J. Lang Z, et al. Among authors: yu z. Cell Death Discov. 2023 Aug 19;9(1):304. doi: 10.1038/s41420-023-01602-y. Cell Death Discov. 2023. PMID: 37598186 Free PMC article.

9

Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma.

Tao Q, Lang Z, Li Y, Gao Y, Lin L, Yu Z, Zheng J, Yu S. Tao Q, et al. Among authors: yu s, yu z. BMC Cancer. 2023 Oct 24;23(1):1029. doi: 10.1186/s12885-023-11521-x. BMC Cancer. 2023. PMID: 37875823 Free PMC article.

10

Ginsenoside Rg3 promotes hepatic stellate cell ferroptosis by epigenetically regulating ACSL4 to suppress liver fibrosis progression.

Hu Y, Lang Z, Li X, Lin L, Li Y, Zhang R, Zheng J, Yu Z. Hu Y, et al. Among authors: yu z. Phytomedicine. 2024 Feb;124:155289. doi: 10.1016/j.phymed.2023.155289. Epub 2023 Dec 16. Phytomedicine. 2024. PMID: 38176269

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,722 results

Search Page

Filters